Ertugliflozin Compared to Other Anti-hyperglycemic Agents as Monotherapy and Add-on Therapy in Type 2 Diabetes: A Systematic Literature Review and Network Meta-Analysis

por McNeill, Ann M., Davies, Glenn, Kruger, Eliza, Kowal, Stacey, Reason, Tim, Ejzykowicz, Flavia, Hannachi, Hakima, Cater, Nilo, McLeod, Euan
Publicado 2019

Challenges in conducting fractional polynomial and standard parametric network meta-analyses of immune checkpoint inhibitors for first-line advanced renal cell carcinoma

por Petersohn, Svenja, McGregor, Bradley, Klijn, Sven L, May, Jessica R, Ejzykowicz, Flavia, Kurt, Murat, Dyer, Matthew, Malcolm, Bill, Branchoux, Sébastien, Nickel, Katharina, George, Saby, Kroep, Sonja
Publicado 2023

Conditional survival and long‐term efficacy with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma

por Motzer, Robert J., McDermott, David F., Escudier, Bernard, Burotto, Mauricio, Choueiri, Toni K., Hammers, Hans J., Barthélémy, Philippe, Plimack, Elizabeth R., Porta, Camillo, George, Saby, Powles, Thomas, Donskov, Frede, Gurney, Howard, Kollmannsberger, Christian K., Grimm, Marc‐Oliver, Barrios, Carlos, Tomita, Yoshihiko, Castellano, Daniel, Grünwald, Viktor, Rini, Brian I., McHenry, M. Brent, Lee, Chung‐Wei, McCarthy, Jennifer, Ejzykowicz, Flavia, Tannir, Nizar M.
Publicado 2022